Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biodesix (BDSX) FCF Margin (2019 - 2025)

Historic FCF Margin for Biodesix (BDSX) over the last 7 years, with Q3 2025 value amounting to 41.01%.

  • Biodesix's FCF Margin rose 190500.0% to 41.01% in Q3 2025 from the same period last year, while for Sep 2025 it was 36.37%, marking a year-over-year increase of 585200.0%. This contributed to the annual value of 72.74% for FY2024, which is 205400.0% up from last year.
  • According to the latest figures from Q3 2025, Biodesix's FCF Margin is 41.01%, which was up 190500.0% from 33.07% recorded in Q2 2025.
  • Biodesix's 5-year FCF Margin high stood at 6.81% for Q2 2021, and its period low was 204.05% during Q1 2022.
  • Over the past 5 years, Biodesix's median FCF Margin value was 90.62% (recorded in 2022), while the average stood at 88.06%.
  • As far as peak fluctuations go, Biodesix's FCF Margin soared by 1114800bps in 2021, and later tumbled by -1632000bps in 2022.
  • Quarter analysis of 5 years shows Biodesix's FCF Margin stood at 148.49% in 2021, then rose by 3bps to 144.46% in 2022, then grew by 28bps to 104.08% in 2023, then soared by 77bps to 24.16% in 2024, then plummeted by -70bps to 41.01% in 2025.
  • Its FCF Margin stands at 41.01% for Q3 2025, versus 33.07% for Q2 2025 and 48.31% for Q1 2025.